Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia
Hematol Oncol
.
2023 Aug;41(3):567-570.
doi: 10.1002/hon.3080.
Epub 2022 Oct 10.
Authors
Riccardo Moia
1
,
Riccardo Dondolin
1
,
Maria Stefania De Propris
2
,
Donatella Talotta
1
,
Samir Mouhssine
1
,
Francesca Perutelli
3
,
Gianluigi Reda
4
,
Veronica Mattiello
4
,
Gian Matteo Rigolin
5
,
Marina Motta
6
,
Jacopo Olivieri
7
,
Renato Fanin
7
,
Omar Perbellini
8
,
Isacco Ferrarini
9
,
Francesca Romana Mauro
2
,
Ilaria Del Giudice
2
,
Luca Laurenti
10
,
Annamaria Tomasso
10
,
Massimo Gentile
11
,
Anna Maria Frustaci
12
,
Alessandra Tedeschi
12
,
Alessandro Gozzetti
13
,
Caterina Stelitano
14
,
Carlo Visco
9
,
Carol Moreno
15
,
Francesco Forconi
16
,
Roberto Marasca
17
,
Marta Coscia
3
,
Davide Rossi
18
,
Robin Foà
2
,
Gianluca Gaidano
1
Affiliations
1
Division of Hematology, Department of Translational Medicine, Università Del Piemonte Orientale, Novara, Italy.
2
Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
3
Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
4
Hematology Unit, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy.
5
Department of Medical Sciences, Hematology Section, AOU Arcispedale S Anna, University of Ferrara, Ferrara, Italy.
6
AO Spedali Civili di Brescia, Lombardia, Italy.
7
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), SOC Clinica Ematologica, Udine, Italy.
8
Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
9
Department of Medicine, Section of Haematology, University of Verona, Verona, Italy.
10
Department of Hematology, Catholic University Hospital A. Gemelli, Rome, Italy.
11
Azienda Ospedaliera of Cosenza, Cosenza, Italy.
12
Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
13
Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
14
U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Di Calabria, Italy.
15
Hospital de La Santa Creu I Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
16
Faculty of Medicine, University of Southampton, Southampton, UK.
17
Department of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy.
18
Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
PMID:
36190298
DOI:
10.1002/hon.3080
No abstract available
Publication types
Multicenter Study
Letter
MeSH terms
Cyclophosphamide
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Mutation
Prognosis
Treatment Outcome
Substances
Cyclophosphamide
Grants and funding
23669/CRUK_/Cancer Research UK/United Kingdom